Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation - Quiz - MDSpire

Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation

  • By

  • Yi-Lun Chiang

  • Tzu-Hao Li

  • Yu-Wei Fang

  • Ya-Fang Liu

  • Jennifer Wu

  • Ming-Hsien Tsai

  • April 13, 2026

  • 0 min

Share

Original Source(s)

Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation

  • by Yi-Lun Chiang, Tzu-Hao Li, Yu-Wei Fang, Ya-Fang Liu, Jennifer Wu, Ming-Hsien Tsai

  • April 13, 2026

Related Content

Case Report and retrospective literature analysis of pediatric lower esophageal squamous cell carcinoma: focus on diagnostic challenges and therapeutic strategies

What RVO May Reveal About Systemic Health

TriNetX data presented at Retina World Congress linked BRVO and CRVO with increased risks of stroke, myocardial infarction, and carotid disease.

Suprachoroidal Injection in the Treatment of Diabetic Macular Edema: Mechanisms, Clinical Advances, and Future Perspectives